Skip to main content
Livermore
Livermore
ZHEN

HighMark Wealth Management LLC

SEC CIK
0001802451
Latest filing
Aug 12, 2026

The latest 13F from HighMark Wealth Management LLC covers Q2 2026 (filed Aug 12, 2026): 561 long positions worth $298.5M. The top 10 holdings make up 65.8% of the portfolio, and the largest is iShares Core S&P 500 ETF at 27.6%. Livermore has 22 filings on Form 13F from this institution, going back to Q1 2021.

What changed in Q2 2026

Share counts compared with Q1 2026: how many positions were new, added to, reduced or sold out, and the biggest buys and sells. Dollar amounts are estimated at the quarter-end prices implied by the filing.

Full comparison
New
43
Est. +$9.09M
Added
156
Est. +$28.8M
Reduced
94
Est. −$16.3M
Sold out
36
Est. −$9.67M

Top 5 holdings

Share of this quarter's portfolio value

  1. iShares Core S&P 500 ETF464287200
    27.6%$82.3M
  2. Fidelity MSCI Health Care Index ETF316092600
    6.6%$19.7M
  3. AXGNAxogen, Inc.
    5.3%$15.8MHistory
  4. iShares Russell 2000 ETF464287655
    5.1%$15.3M
  5. iShares Tr464288877
    5.1%$15.2M

Biggest buys

New and added positions, by estimated amount bought

  1. Fidelity MSCI Health Care Index ETF316092600
    +$19.7MAdded
  2. SIBNSI-BONE, Inc.
    +$4.33MAddedHistory
  3. APGEApogee Therapeutics, Inc.
    +$4.28MNewHistory
  4. DUOTDuos Technologies Group, Inc.
    +$3.48MNewHistory
  5. NPCENeuroPace Inc
    +$1.59MAddedHistory

Largest weight increases

New and added positions, by percentage points of the portfolio gained

  1. Fidelity MSCI Health Care Index ETF316092600
    +6.58 pp<0.1% → 6.6%
  2. SIBNSI-BONE, Inc.
    +1.50 pp0.8% → 2.3%History
  3. APGEApogee Therapeutics, Inc.
    +1.43 pp0.0% → 1.4%History
  4. NEONeogenomics Inc
    +1.24 pp1.8% → 3.0%History
  5. DUOTDuos Technologies Group, Inc.
    +1.17 pp0.0% → 1.2%History

Biggest sells

Reduced and sold-out positions, by estimated amount sold

  1. CNTACentessa Pharmaceuticals plc
    −$9.41MSold outHistory
  2. iShares Core S&P 500 ETF464287200
    −$5.29MReduced
  3. ANABAnaptysbio, Inc
    −$3.67MReducedHistory
  4. iShares Tr464288877
    −$1.62MReduced
  5. PIPRPiper Sandler Companies
    −$1.13MReducedHistory

Largest weight decreases

Reduced and sold-out positions, by percentage points of the portfolio lost

  1. CNTACentessa Pharmaceuticals plc
    −3.83 pp3.8% → 0.0%History
  2. iShares Core S&P 500 ETF464287200
    −3.45 pp31.0% → 27.6%
  3. iShares Tr464288877
    −1.56 pp6.7% → 5.1%
  4. ANABAnaptysbio, Inc
    −1.23 pp2.1% → 0.9%History
  5. iShares Core S&P US Value ETF464287663
    −0.56 pp3.3% → 2.8%

Metrics

13F metrics for Q2 2026, computed only from the numbers in the filings. Definitions below.

Portfolio value
$298.5M
+$52.9M (+21.5%) vs. prior quarter
Positions
561
+7 vs. prior quarter
Top 10 concentration
65.8%
Top 10 as share of value
Turnover
9.5%
Q2 2026, one quarter
Average holding period
18.8 quarters
Weighted by value

How these are calculated

  • Portfolio value: the market value of all long positions in the 13F, as reported at quarter end, excluding options.
  • Top 10 concentration: the combined value of the 10 largest positions as a share of portfolio value.
  • Turnover: the smaller of this quarter's estimated purchases and estimated sales, divided by the average of this and last quarter's portfolio value. Estimates multiply the change in shares by the quarter-end price implied by the filing (market value divided by shares); new positions use this quarter's value and sold-out positions last quarter's. Only positions reported in shares count, and it is not calculated when the previous quarter was not filed.
  • Average holding period: how many consecutive quarters each current position has been held (including this one; a quarter without the position or without a filing starts the count over), weighted by this quarter's value. Counting starts with the first 13F in Livermore (Q1 2021), so positions held before then are understated.

13F filings by quarter

22 quarters, going back to Q1 2021. Bars show each quarter's 13F portfolio value; quarters without a filing are left blank.

Peak $298.5M (Q2 2026)

Q1 2021: $125.4MQ2 2021: $136.1MQ3 2021: $135.9MQ4 2021: $157.8MQ1 2022: $149.5MQ2 2022: $124.4MQ3 2022: $117.1MQ4 2022: $132.6MQ1 2023: $128.2MQ2 2023: $133.1MQ3 2023: $120.6MQ4 2023: $135.4MQ1 2024: $161.5MQ2 2024: $166.2MQ3 2024: $182.7MQ4 2024: $173.9MQ1 2025: $169.3MQ2 2025: $204.5MQ3 2025: $227.1MQ4 2025: $245.4MQ1 2026: $245.6MQ2 2026: $298.5M
Q1 2021Q2 2026
13F filings of HighMark Wealth Management LLC by quarter
QuarterFiledPositionsValueTop 3 holdingsChangesFiling
Q2 2026Aug 12, 2026561$298.5MiShares Core S&P 500 ETFFidelity MSCI Health Care Index ETFAXGNvs. Q1 2026SEC
Q1 2026May 6, 2026554$245.6MiShares Core S&P 500 ETFiShares TriShares Russell 2000 ETFvs. Q4 2025SEC
Q4 2025Feb 5, 2026587$245.4MiShares Core S&P 500 ETFiShares TriShares Russell 2000 ETFvs. Q3 2025SEC
Q3 2025Oct 20, 2025607$227.1MiShares Core S&P 500 ETFiShares TriShares Russell 2000 ETFvs. Q2 2025SEC
Q2 2025Jul 21, 2025616$204.5MiShares Core S&P 500 ETFiShares TriShares Russell 2000 ETFvs. Q1 2025SEC
Q1 2025Apr 24, 2025574$169.3MiShares Core S&P 500 ETFiShares TriShares Russell 2000 ETFvs. Q4 2024SEC
Q4 2024Jan 31, 2025575$173.9MiShares Core S&P 500 ETFiShares TriShares Russell 2000 ETFvs. Q3 2024SEC
Q3 2024Oct 17, 2024596$182.7MiShares Core S&P 500 ETFiShares TriShares Russell 2000 ETFvs. Q2 2024SEC
Q2 2024Jul 29, 2024587$166.2MiShares Core S&P 500 ETFiShares TriShares Russell 2000 ETFvs. Q1 2024SEC
Q1 2024Apr 29, 2024567$161.5MiShares Core S&P 500 ETFiShares TriShares Russell 2000 ETFvs. Q4 2023SEC
Q4 2023Jan 23, 2024576$135.4MiShares Core S&P 500 ETFiShares TriShares Core S&P Small Cap ETFvs. Q3 2023SEC
Q3 2023Oct 18, 2023566$120.6MiShares Core S&P 500 ETFiShares TriShares Core S&P Small Cap ETFvs. Q2 2023SEC
Q2 2023Jul 26, 2023563$133.1MiShares Core S&P 500 ETFiShares TriShares Core S&P Small Cap ETFvs. Q1 2023SEC
Q1 2023Apr 21, 2023604$128.2MiShares Core S&P 500 ETFiShares TriShares Core S&P Small Cap ETFvs. Q4 2022SEC
Q4 2022Feb 2, 2023543$132.6MiShares Core S&P 500 ETFiShares TrSPDR Index Shs FDSvs. Q3 2022SEC
Q3 2022Oct 21, 2022551$117.1MiShares Core S&P 500 ETFiShares TrSPDR Index Shs FDSvs. Q2 2022SEC
Q2 2022Jul 19, 2022545$124.4MiShares Core S&P 500 ETFiShares TrSPDR Index Shs FDSvs. Q1 2022SEC
Q1 2022Apr 25, 2022521$149.5MiShares Core S&P 500 ETFiShares TrSPDR Index Shs FDSvs. Q4 2021SEC
Q4 2021Jan 20, 2022505$157.8MiShares Core S&P 500 ETFiShares TrSPDR Index Shs FDSvs. Q3 2021SEC
Q3 2021Nov 1, 2021509$135.9MiShares Core S&P 500 ETFiShares TrSPDR Index Shs FDSvs. Q2 2021SEC
Q2 2021Aug 2, 2021512$136.1MiShares Core S&P 500 ETFiShares TrSPDR Index Shs FDSvs. Q1 2021SEC
Q1 2021Apr 22, 2021486$125.4MiShares Core S&P 500 ETFiShares TrSPDR Index Shs FDS–SEC